SEC FORM 3

SEC FORM 3SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Levy Raphi

(Last)

(First)

(Middle)

C/O ALPHA TAU MEDICAL

PO BOX 45044

(Street)

JERUSALEM

9777605

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Alpha Tau Medical Ltd. [ DRTS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	180,180	D
Restricted Share Units⁽¹⁾	23,996	D
Restricted Share Units⁽²⁾	54,433	D
Restricted Share Units⁽³⁾	49,117	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options⁽⁴⁾	09/04/2019	06/04/2029	Ordinary Shares	325,905	$4.03	D
Options⁽⁴⁾	06/04/2019	06/04/2029	Ordinary Shares	36,212	$4.03	D
Options⁽⁴⁾	08/16/2022	06/04/2029	Ordinary Shares	45,265	$4.03	D
Options⁽⁴⁾	03/07/2022	06/04/2029	Ordinary Shares	90,529	$4.03	D
Options⁽⁴⁾	09/03/2020	09/03/2030	Ordinary Shares	45,265	$4.42	D
Options⁽⁴⁾	06/07/2022	08/08/2031	Ordinary Shares	86,545	$11.5	D
Options⁽⁴⁾	06/07/2022	03/21/2032	Ordinary Shares	70,724	$10.92	D
Options⁽⁴⁾	06/07/2022	06/02/2032	Ordinary Shares	80,360	$7.19	D
Options⁽⁴⁾	04/01/2023	03/09/2033	Ordinary Shares	328,458	$3.28	D
Options⁽⁵⁾	04/01/2024	03/07/2034	Ordinary Shares	301,880	$2.98	D
Options⁽⁶⁾	04/01/2025	03/12/2035	Ordinary Shares	267,641	$2.6	D
Options⁽⁷⁾	04/01/2026	03/09/2036	Ordinary Shares	158,882	$6.41	D

Explanation of Responses:

1. These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2024, subject to the Reporting Person's continued service.

2. These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2025, subject to the Reporting Person's continued service.

3. These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2026, subject to the Reporting Person's continued service.

4. These are options to acquire ordinary shares, which have fully vested as of the date hereof.

5. These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2024, subject to the Reporting Person's continued service.

6. These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2025, subject to the Reporting Person's continued service.

7. These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2026, subject to the Reporting Person's continued service.

	/s/ Raphael Levy	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

SEC Form 3 filed by new insider Levy Raphi